Skip to main content
Log in

Recombinant adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene suppresses human pancreatic cancer growth

  • Published:
The Chinese-German Journal of Clinical Oncology

Abstract

Objective

To investigate the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene transfection mediated by adenovirus into human pancreatic carcinoma cell line Panc-1, and the mechanisms involved in this effect.

Methods

TRAIL gene was transfected into pancreatic cancer cell line Panc-1 by an adenovirus vector (Ad-TRAIL). Level of TRAIL mRNA expression was determined using RT-PCR, and TRAIL protein synthesis was evaluated with Western blot. Cell-growth activities were determined by MTT assay. The bystander effect was observed by co-culturing the Panc-1 cells with the transfected TRAIL gene at different ratios. Apoptosis in pancreatic cancer cells was detected by flow cytometry. Procaspase-8 and procaspase-3 were determined by Western blot.

Results

The stable overexpression of TRAIL was detected in Panc-1 cells transfected by Ad-TRAIL. Ad-TRAIL significantly inhibited of cell viability of Panc-1 cells. Furthermore, co-culture of cancer cells transfected with TRAIL with that nontransfected resulted in the cell death of both cells by bystander effect. Moreover, the percentage of apoptotic cells was significantly higher in the Ad-TRAIL-treatment group compared to the control groups (P < 0.01). And there was a diminished amount of procaspase-8 and procaspase-3 after infection with Ad-TRAIL.

Conclusion

The overexpression of TRAIL gene in Panc-1 cells by Ad-TRAIL exerts its antitumor effects, and the mechanisms involved in this effect may be proapoptosis and bystander effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med, 1999, 5: 157–163.

    Article  PubMed  CAS  Google Scholar 

  2. Chen L, Liu Q, Qin R, et al. Amplification and functional characterization of MUC1 promoter and gene-virotherapy via a targeting adenoviral vector expressing hSSTR2 gene in MUC1-positive Panc-1 pancreatic cancer cells in vitro. Int J Mol Med, 2005, 15: 617–626.

    PubMed  CAS  Google Scholar 

  3. Chen LM, Le HY, Qin RY, et al. Reversal of the phenotype by K-rasval12 silencing mediated by adenovirus-delivered siRNA in human pancreatic cancer cell line Panc-1. World J Gastroenterol, 2005, 11: 831–838.

    Article  PubMed  CAS  Google Scholar 

  4. Ashkenazi A, Pai RC, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest, 1999, 104: 155–162.

    Article  PubMed  CAS  Google Scholar 

  5. Ibrahim SM, Ringel J, Schmidt C, et al. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death. Pancreas, 2001, 23: 72–79.

    Article  PubMed  CAS  Google Scholar 

  6. Verma IM, Somia N. Gene therapy-promises, problems and prospects. Nature, 1997, 389: 239–242.

    Article  PubMed  CAS  Google Scholar 

  7. Walczak H, Bouchon A, Stahl H, et al. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2-or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Cancer Res, 2000, 60: 3051–3057.

    PubMed  CAS  Google Scholar 

  8. Eggert A, Grotzer MA, Zuzak TJ, et al. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res, 2001, 61: 1314–1319.

    PubMed  CAS  Google Scholar 

  9. Satoh K, Kaneko K, Hirota M, et al. Tumor necrosis factor-related apoptosis-inducing ligand and its receptor expression and the pathway of apoptosis in human pancreatic cancer. Pancreas, 2001, 23: 251–258.

    Article  PubMed  CAS  Google Scholar 

  10. Daniel PT, Wieder T, Sturm I, et al. The kiss of death: promises and failures of death receptors and ligands in cancer therapy. Leukemia, 2001, 15: 1022–1032.

    Article  PubMed  CAS  Google Scholar 

  11. Mesnil M, Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res, 2000, 60: 3989–3999.

    PubMed  CAS  Google Scholar 

  12. Shao R, Xia W, Hung MC. Inhibition of angiogenesis and induction of apoptosis are involved in E1A-mediated bystander effect and tumor suppression. Cancer Res, 2000, 60: 3123–3126.

    PubMed  CAS  Google Scholar 

  13. Bai S, Du L, Liu W, et al. Tentative novel mechanism of the bystander effect in glioma gene therapy with HSV-TK/GCV system. Biochem Biophys Res Commun, 1999, 259: 455–459.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Renyi Qin.

Additional information

Supported by a grant from the National Natural Science Foundation of China (No. 30471693).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tian, R., Qin, R., Du, Z. et al. Recombinant adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene suppresses human pancreatic cancer growth. Chinese German J Clin Oncol 6, 464–468 (2007). https://doi.org/10.1007/s10330-007-0013-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10330-007-0013-8

Key words

Navigation